New combination therapy for pancreatic carcinomas and colon cancer
The current invention is based on combination therapies of nucleoside analogs with inhibitors of either the Nodal/Activin pathway or the mTOR / hedgehog pathway and show a remarkable capacity to eliminate cancer stem cells
and to subsequently inhibit pancreatic and/or colon cancer.
Further Information: PDF
Bayerische Patentallianz GmbH
Phone: +49 89 5480177-0
Contact
Peer Biskup
Media Contact
All news from this category: Technology Offerings
Latest posts
Acute itching in eczema patients linked to environmental allergens
Newly identified pathway explains why antihistamine drugs often don’t work to control severe itch. In addition to a skin rash, many eczema sufferers also experience chronic itching, but sometimes that…
Simulating evolution to understand a hidden switch
Computer simulations of cells evolving over tens of thousands of generations reveal why some organisms retain a disused switch mechanism that turns on under severe stress, changing some of their…
How cells move and don’t get stuck
Cell velocity, or how fast a cell moves, is known to depend on how sticky the surface is beneath it, but the precise mechanisms of this relationship have remained elusive…
